Evotec SE (EVO) Notes Payables (2009 - 2010)

Evotec SE (EVO) reported Notes Payables of $1138.9 for Q3 2010, down 9.12% sequentially from $1253.2 in Q2 2010.

Evotec SE (EVO) Notes Payables (2009 - 2010) Analysis & Trends

Evotec SE (EVO) has 2 years of Notes Payables data on file, last reported at $1138.9 in Q3 2010.

For the quarter ending Q3 2010, Notes Payables changed N/A year-over-year to $1138.9; the trailing twelve-month figure through Sep 2010 stood at $1138.9 (changed N/A YoY), and the FY2009 full-year result was $1167.6, changed N/A from the prior year.
Notes Payables fell to $1138.9 in Q3 2010, from $1253.2 in the prior quarter.
In the past five years, Notes Payables ranged from a high of $1.2 million in Q1 2009 to a low of $1138.9 in Q3 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Evotec SE	351.60 Mn	351.08 Mn	-

Historic Data

Download Data

Date	Value
Sep 30, 2010	1,138.90
Jun 30, 2010	1,253.17
Mar 31, 2010	1,159.00
Dec 31, 2009	1,236.03
Jun 30, 2009	1.15 Mn
Mar 31, 2009	1.20 Mn